Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-033839
Filing Date
2025-07-02
Accepted
2025-07-02 08:21:38
Documents
2
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751458890.html 4  
1 FORM 4 wk-form4_1751458890.xml 4 3834
2 EX-24 thompsonpoa.htm EX-24 13129
  Complete submission text file 0001628280-25-033839.txt   18529
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
THOMPSON JOHN CRAIG (Reporting) CIK: 0001509643 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 251098386